Choo Chee Kong

Director, 10% Owner · CytoMed Therapeutics Ltd

Every open-market stock purchase Choo Chee Kong has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where how the prices paid compare to where the stock trades now.

Total bought

$728.8K

Open-market buys

Companies

Last buy

Jul 20, 2026

Where the buys stand today

GDTC
CytoMed Therapeutics Ltd
5 purchases totalling $728.8K at an average of $1.42 per share. See all insider buying in GDTC →
Avg price paid
$1.42
Latest price
—
Market cap
Unknown

All reported buys

Date	Ticker	Shares	Price	Value	Filing
Jul 20, 2026	GDTC	100,000	$1.50	$150.0K	SEC ↗
Jul 20, 2026	GDTC	100,000	$1.50	$150.0K	SEC ↗
Jul 14, 2026	GDTC	100,000	$1.50	$150.0K	SEC ↗
Jul 14, 2026	GDTC	100,000	$1.50	$150.0K	SEC ↗
May 13, 2026	GDTC	112,000	$1.15	$128.8K	SEC ↗

Follow new qualifying clusters involving Choo Chee Kong or other insiders

Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.

Start a trial See pricing

About this data

Figures are parsed from Choo Chee Kong's Form 4 filings on SEC EDGAR (CIK 1970632) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.

This page is informational and reflects public filing data. It is not investment advice.